Heart intertwined with circuitry, representing technology and healthcare.

Beyond Blood Transfusions: How Modern Technology is Revolutionizing Cardiac Surgery

Samir D’Costa in Health & Wellness August 2025 • 4 min read.

"Discover how thromboelastometry is transforming transfusion practices and improving outcomes in heart surgery, potentially reducing risks and recovery times."

Cardiac surgery, while life-saving, has always been associated with significant blood loss and the subsequent need for transfusions. These transfusions, while necessary, carry their own set of risks, including adverse reactions and increased recovery times. For years, doctors have sought ways to minimize these risks and improve patient outcomes. Now, a new approach is changing the landscape.

Enter thromboelastometry, a cutting-edge technology that provides real-time insights into a patient's blood clotting process. Unlike traditional methods that can take hours, thromboelastometry delivers results quickly, allowing medical teams to make informed decisions about transfusions and other interventions. This rapid feedback is crucial in managing bleeding and ensuring that patients receive only what they truly need.

The buzz around thromboelastometry is growing, with recent studies highlighting its potential to reduce blood transfusions and improve overall patient care. As this technology becomes more integrated into surgical practices, it promises a future where cardiac surgeries are safer, more efficient, and less reliant on traditional blood transfusion methods.

The Rise of Thromboelastometry: A New Era in Blood Management

Heart intertwined with circuitry, representing technology and healthcare.

Thromboelastometry, on the other hand, offers a dynamic assessment of blood clotting. By analyzing how blood clots form and break down in real-time, it provides a more complete picture of a patient's coagulation status. This technology allows doctors to identify specific clotting deficiencies and tailor their treatment accordingly, ensuring that patients receive the precise blood components they need, rather than a one-size-fits-all approach.

Faster Results: Real-time data enables quicker, more informed decisions.
Targeted Treatment: Precise identification of clotting issues leads to tailored interventions.
Reduced Transfusions: Minimizing unnecessary blood product usage lowers risk.
Improved Outcomes: Better management of bleeding contributes to faster recovery.

The introduction of thromboelastometry and similar point-of-care (POC) tests marks a significant shift towards personalized medicine in cardiac surgery. These technologies are not just about reducing blood transfusions; they're about optimizing patient care by providing clinicians with the tools they need to make the best possible decisions.

The Future is Personalized: Embracing Technology for Better Cardiac Care

As technology advances, the field of cardiac surgery continues to evolve. Thromboelastometry is just one example of how innovation is driving improvements in patient care. By embracing these new tools and approaches, medical professionals can provide safer, more effective treatments, ultimately leading to better outcomes and a higher quality of life for those undergoing heart surgery.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

What exactly is thromboelastometry, and how does it improve cardiac surgery outcomes?

Thromboelastometry is a technology that offers real-time analysis of a patient's blood clotting process. Unlike traditional methods, it provides rapid results, allowing medical teams to make informed decisions about transfusions and interventions quickly. This leads to better management of bleeding during and after cardiac surgery, ultimately reducing the need for unnecessary blood transfusions and improving patient outcomes. While other point-of-care tests also exist, thromboelastometry's comprehensive assessment of clot formation and breakdown distinguishes it.

How does traditional blood management in cardiac surgery differ from the approach using thromboelastometry?

Traditional blood management in cardiac surgery often relies on standard laboratory tests (SLTs) like Clauss fibrinogen, prothrombin time (PT), and activated thromboplastin time (aPTT). These tests have limitations because they take time to process, and their predictive value in determining bleeding risks is not always accurate. This can lead to unnecessary transfusions, exposing patients to potential complications that could be avoidable with the use of thromboelastometry. Thromboelastometry is a big improvement and can determine the need for blood products and the status of the patient intraoperatively.

How does thromboelastometry help personalize blood transfusions during cardiac surgery?

By using thromboelastometry, doctors can identify specific clotting deficiencies in real-time and tailor their treatment accordingly. This personalized approach ensures that patients receive the precise blood components they need, rather than a one-size-fits-all approach, which is common with standard laboratory tests (SLTs). Thromboelastometry allows for the assessment of how blood clots form and break down, providing a detailed view of a patient's coagulation status. Further development is needed to include other parameters in thromboelastometry results.

What are the main advantages of using thromboelastometry in cardiac surgery?

The benefits of thromboelastometry include faster results, which enable quicker and more informed decisions. It also offers targeted treatment by precisely identifying clotting issues, leading to tailored interventions. This results in reduced transfusions by minimizing unnecessary blood product usage, thus lowering risks and ultimately improving outcomes by contributing to faster recovery. However, thromboelastometry needs to be combined with clinical assessments to obtain the most accurate information.

Beyond thromboelastometry, what other advancements contribute to improving patient outcomes in cardiac surgery?

While thromboelastometry offers significant advantages in managing blood transfusions during cardiac surgery, it is essential to recognize that it is one component of a broader strategy for optimizing patient care. Other advancements, such as improved surgical techniques, enhanced anesthesia protocols, and comprehensive post-operative care, also play crucial roles in improving patient outcomes. Combining these advancements with thromboelastometry leads to improved results. Further areas of focus are reducing inflammation post surgery and accelerated rehabilitation programs.